Please use this identifier to cite or link to this item: https://dspace.univ-ouargla.dz/jspui/handle/123456789/23087
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAbdelkader HAMADI-
dc.contributor.authorAimad DATOUSSAID-
dc.date.accessioned2020-02-05T11:00:22Z-
dc.date.available2020-02-05T11:00:22Z-
dc.date.issued2019-
dc.identifier.issn2437-0843-
dc.identifier.urihttp://dspace.univ-ouargla.dz/jspui/handle/123456789/23087-
dc.descriptionRevue El Bahithen_US
dc.description.abstractOstrom's (1990) work on natural resources is one of the new models of governance and invites us to take a fresh look at how we think about politics, through which it opened a gap in understanding how individuals and organizations self-organize to collectively reap the benefits of renewable resources. We support the hypothesis that the notion of access to medicines must be considered as a common good in the Algerian health context. It should be carried out within the framework of "Focal Monopoly of Governance" presented by Meisel (2004) and is considered as a potential response to the institutional and political blockages of access to medicines in Algeria. We use the term "Focal Monopoly of Governance" to apply it to the question of access to medicines in Algeria, as a way of overtaking to coordinate the divergent interests between actors. This FMG would be intended to cover the needs of essential medicines under four levers of accessibility: qualitative, legal, economic and geographic.en_US
dc.language.isofren_US
dc.relation.ispartofseriesnuméro 19 2019;-
dc.subjectAlgeriaen_US
dc.subjectCommon gooden_US
dc.subjectChangeen_US
dc.subjectAccess to medicinesen_US
dc.titleEndogenous institutional change in favor of access to medicines: the case of Algeriaen_US
dc.typeArticleen_US
Appears in Collections:numéro 19 2019

Files in This Item:
File Description SizeFormat 
R1936F.pdf240,82 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.